School of Medicine
Showing 1-100 of 227 Results
-
Fahim Abbasi
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Fahim Abbasi specializes in diagnosis and treatment of prediabetes and insulin resistance. Dr. Abbasi has a special interest in prevention of diabetes and cardiovascular disease through lifestyle modifications.
-
Kevin M. Alexander, MD, FACC, FHFSA
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Alexander is an advanced heart failure-trained cardiologist. He is also an Assistant Professor of Cardiovascular Medicine at Stanford University School of Medicine.
Dr. Alexander specializes in the management of advanced heart failure and transplant cases, seeing a wide range of patients. He also has an active research laboratory, studying various forms of heart failure.
Dr. Alexander has expertise in diagnosing and treating transthyretin cardiac amyloidosis, a critical yet underdiagnosed cause of heart failure among African Americans and the elderly. He is conducting extensive research to enhance our understanding of this condition, with grant support from the National Institutes of Health and American Heart Association, among other sources. -
Maryam Amirahmadi
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Maryam Amirahmadi is a microsurgery expert and postdoctoral research fellow at Stanford Cardiovascular Institute. She obtained her Doctor of Medicine (MD) degree from Hamadan University of Medical Sciences. After more than a year of experience as a Family and Emergency Physician, she spent around 4 years at the Department of Cardiovascular Surgery of Shiraz University of Medical Sciences where she served as a pediatric and adult Cardiac Intensive Care physician and received training in cardiovascular surgery at Namazi and Faghihi hospitals. She then spent a year in the Department of Vascular Surgery at the University of Miami, Miller School of Medicine, serving as a postdoctoral researcher and performing microsurgery on animals, with her research focused on therapeutic strategies to improve neovascularization after limb ischemia. Dr. Amirahmadi joined Stanford Cardiovascular Institute in 2022 where she is now a postdoctoral research fellow under the supervision of Prof. Philip S. Tsao, a renowned cardiovascular scientist. Her research interests and practical expertise include Microsurgery, and the effect of e-cigarette vaping on factors of inflammatory or immune pathways that can subsequently be related to the molecular mechanisms involved in angiogenesis and arteriogenesis in the murine model of hindlimb ischemia, as well as the mechanisms of e-cigarette and nicotine’s effects in augmenting Abdominal Aortic Aneurysm (AAA) in rodent models of aortic aneurysm, including porcine pancreatic elastase-induced AAA. Dr. Maryam Amirahmadi and her colleagues are currently investigating the transgenerational effects of vaping/nicotine on abdominal aortic aneurysm (AAA) risk.
-
Daniel Kwasi Amponsah
Fellow in Medicine - Med/Cardiovascular Medicine
BioDr. Daniel Amponsah was born and raised in Loma Linda, California. He graduated with a BS in Biochemistry from Pacific Union College in Northern California and received his MD from Loma Linda University School of Medicine where he graduated AOA. He completed his internal medicine residency at Massachusetts General Hospital and was appointed the Simulation Chief his senior year. He is interested in pursuing an academic career in interventional cardiology with a focus on outcomes and health disparities. Prior research work has explored outcomes in ischemic time in patients with cardiogenic shock and STEMI with Dr. Anthony Hilliard, disparities in the management of aortic stenosis alongside Dr. Sammy Elmariah, defining type 2 MI using coronary CT with Dr. James Januzzi. He is presently engaged in assessing the potential applications of angiography-derived FFR and IMR across various coronary disease syndromes with Dr. Bill Fearon and investigating disparities in advanced structural interventions with Dr. Celina Yong.
-
Themistocles (Tim) Assimes
Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsGenetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes
-
Adrian Matias Bacong
Postdoctoral Scholar, Cardiovascular Medicine
Current Research and Scholarly InterestsAdrian M. Bacong, PhD, MPH is a social epidemiologist by training. His research seeks to identify social and structural factors that underlie health inequities by race, ethnicity, and immigration status. Specifically, his work has explored the role of socioeconomic factors in explaining health disparities by immigrant legal status and visa type. Furthermore, Adrian is interested in the effects of immigration on health. He received a NIH F31 award (1F31MD015931-01A1) to examine factors affecting the health of Filipino migrants to the U.S. compared to Filipinos remaining in the Philippines.
Adrian has also examined the intersections of race, ethnicity, and immigration status among older adults. Finally, Adrian written upon the role of data disaggregation as a method of public health critical race praxis. Currently, Adrian is researching the role of social and policy level factors underlying health disparities among immigrants. -
Nitish Badhwar
Clinical Professor, Medicine - Cardiovascular Medicine
BioNitish Badhwar, MD is Professor of Medicine and Director of Cardiac Electrophysiology Training Program at Stanford University School of Medicine. Dr. Badhwar received his medical degree from Maulana Azad Medical College (University of Delhi, India). After completing his internal medicine training from New York Hospital of Queens (affiliated with Cornell Medical School), he worked as faculty in the Department of Medicine at Hospital of St. Raphael (Yale University School of Medicine). He completed Cardiac Electrophysiology training at UCSF with Dr. Scheinman. After being on faculty at UCSF for 15 years he recently joined the Arrhythmia Service at Stanford Hospital. He is a Fellow of American College of Cardiology and Heart Rhythm Society. He has been named best doctor in cardiac electrophysiology in San Francisco Magazine 3 years in a row (2015-2017). This is nominated by his peers. He was given Excellence in Teaching award in Medical Education by Academy of Medical Educators in 2015. He was an invited speaker at prestigious international meetings including Oriental Congress of Cardiology (OCC) in Shanghai, China; Cardiostim EHRA /Europace in Nice, France; Asia Pacific Heart Rhythm Society (APHRS) in Seoul, S Korea; American Heart Association Annual Scientific Session in New Orleans, LA and Indian Heart Rhythm Society in New Delhi, India.
Clinical Interest: Dr. Badhwar's clinical interest is in complex catheter ablation procedures including mapping and ventricular tachycardia (VT), atrial fibrillation (AF) and supraventricular tachycardia (SVT) including junctional variants of SVT. He started the epicardial ablation program at UCSF and also worked with Dr. Randall Lee to perform the first percutaneous epicardial left atrial appendage (LAA) ligation in the Bay Area in patients with atrial fibrillation. He has also differentiated himself in the field of electrophysiology by performing hybrid procedures with CT surgeons in patients with AF and VT. He is also involved in device implantation including pacemakers, ICD and biventricular pacing for heart failure.
Research Interest: Dr. Badhwar has published electrophysiologic characteristics of SVTs including atrial tachycardia arising from the coronary sinus musculature, para-hisian atrial tachycardia, left sided AVNRT, junctional tachycardia and nodofascicular tachycardia. He has also published on the use of nuclear medicine (ERNA) in assessing left ventricular dyssynchrony as well as optimal pacing sties in patients with heart failure requiring biventricular pacing. He has described the unique clinical characteristics of epicardial idiopathic VT arising from the cardiac crux. He has also published clinical outcomes of combining LAA ligation with catheter ablation of atrial fibrillation perform (first in human percutaneous closed chested Maze procedure) and is now part of a multi-center randomized study comparing standard ablation to ablation plus LAA ligation in patients with persistent atrial fibrillation (aMAZE trial). -
Tina Baykaner
Assistant Professor of Medicine (Cardiovascular Medicine)
BioTina Baykaner is an Assistant Professor in the Department of Internal Medicine, Division of Cardiovascular Medicine and Electrophysiology. Following internal medicine residency, cardiovascular medicine and advanced heart failure fellowship trainings at University of California, San Diego and electrophysiology fellowship at Stanford University, Dr. Baykaner joined Stanford University faculty in 2018. She has published over 200 papers, book chapters and abstracts including over 100 original peer-reviewed articles, and delivered over 100 invited presentations in national and international meetings. She serves as associate editor, section editor and editorial board member of four electrophysiology journals and served in guideline writing committees.
Dr. Baykaner’s current research interests include outcomes research, epidemiology and mechanisms of rhythm disorders. She is currently funded by the National Institutes of Health to study patient related outcomes regarding atrial fibrillation (AF) ablation. She received prior research funding from American Heart Association and Heart Rhythm Society. Dr. Baykaner's clinical practice focuses on ablation of atrial and ventricular arrhythmias, SVTs, inappropriate sinus tachycardia management, device implantation and device extraction.
Dr. Baykaner is an active member of American Heart Association (AHA), American College of Cardiology (ACC), Heart Rhythm Society (HRS) and European Society of Cardiology (ESC). She serves as an elected member of the Digital Health Committee for HRS, and previously served as an elected member of the HRS Communications Committee and ACC Task Force ICD research committee. -
Rupan Bose, MD, MB
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioRupan Bose, MD, MB, is a Cardiologist and Clinical Assistant Professor in the Division of Cardiovascular Medicine at Stanford. He specializes in Preventive Cardiology, with a particular focus on high-risk populations.
Dr. Bose completed his medical degree from the Keck School of Medicine of USC. He then completed his internal medicine residency at USC, followed by his fellowship in cardiovascular medicine at Harbor-UCLA. He also has a particular interest in the intersection of medicine and technology, and he holds Masters in Biotechnology (MB) with an emphasis on Bioinformatics from the University of Pennsylvania. His research interests are investigating the underlying cardiovascular drivers of risk in high-risk ethnic groups, as well as investigating the role of emerging technologies and innovations in promoting cardiovascular disease monitoring and outcomes.
At Stanford, Dr. Bose serves in the Preventive Cardiology clinic and the Stanford South Asian Translational Heart Initiative (SSATHI) clinics, as well as in the inpatient cardiovascular services. -
Pauline Brochet
Postdoctoral Scholar, Cardiovascular Medicine
BioPauline Brochet is a French scientist from Souraide, France. She completed her undergraduate studies in Molecular, Cellular and Physiological Biology (BSc, Université Clermont-Auvergne) and earned a Master's degree in Software Development and Data Analysis (MSc, Aix-Marseille Université). Pauline pursued a PhD at TAGC (Theories and Approaches for Genomic Complexity) in Marseille, France.
Under the supervision of Dr. Christophe Chevillard and Dr. Lionel Spinelli, Pauline integrated multi-omics data from human heart tissue to investigate the pathogenic processes associated with Chagas Disease Cardiomyopathy (CCC). Notably, she contributed to the development of ChagasDB, the first database associating key features with the different stages of Chagas disease. Her research identified the involvement of mitochondrial DNA mutations, non-coding RNA, transcription factors, and DNA methylation in various pathogenic processes, all leading to the progression of CCC.
Currently, at Stanford University, under the guidance of Dr. Matthew Wheeler and Dr. Daniel Katz, Pauline is conducting postdoctoral research on multi-omics data analysis as part of the Molecular Transducers of Physical Activity Consortium (MoTrPAC). Her work focuses on identifying key covariable features associated with physical exercise, with the ultimate goal of discovering exercise-mimetic drugs that could help prevent heart diseases. -
Cristina Cadenas Sanchez
Visiting Postdoctoral Scholar, Medicine - Med/Cardiovascular Medicine
BioDr. Cadenas-Sanchez is a Marie Curie postdoctoral fellow at Stanford University and at the Palo Alto VA Health Care System. Her research is focused on: i) the effect of exercise program on brain and physical health in children with obesity; ii) the effect of exercise on different fat depots (intermuscular, pancreatic, visceral, subcutaneous, and hepatic fat) in children with obesity; and iii) the cancer and non-communicable disease prevention through physical fitness/physical activity. She is currently running as principal investigator the PreCaFit (Prevention Cancer through physical fitness, European Union-funded) project which examines the relationship between fitness, physical activity and cancer. Further, to ensure the scalability of the results, PreCaFit project will examine the effects of exercise on cancer biomarkers.
She earned her bachelor's, master's and doctorate's degree from the University of Granada (Spain). She has more than 100 scientific articles (indexed in Journal Citation report), and several books and book-chapters published. Some of the articles have been published in high-impact journals (JAMA Network Open, Diabetes Care, Sports Medicine, Journal of Hepatology, etc.), of which four are/have been considered as highly cited papers (Thomson Reuters). She is recognized as a worldwide expert (among top-15) on physical fitness and cardiorespiratory fitness by ExpertScape. She was also selected as one of the most highlighted Spanish women researcher (including non-Spanish women but working in a Spanish institution) by the Spanish National Research Council. Also, she has received several awards as best young researcher. -
Stephen Chang, MD, PhD
Instructor, Biochemistry
Instructor, Medicine - Cardiovascular MedicineBioPrior to a career in medicine, Dr. Chang was an English major and subsequent novelist at night. During the days, he taught literature part-time at Rutgers University, and for extra money, worked in a laboratory in NYC washing test tubes. Inspired by his laboratory mentor, he began volunteering at the hospital next door, and developed a love for interacting with patients. Through this experience, he saw how caring for others could form deep bonds between people - even strangers - and connect us in a way that brings grandeur to ordinary life.
In addition to seeing patients, Dr. Chang is a physician-scientist devoted to advancing the field of cardiovascular medicine. His research has been focused on identifying a new genetic organism that better models human heart disease than the mouse. For this purpose, he has been studying the mouse lemur, the smallest non-human primate, performing cardiovascular phenotyping (vital signs, ECG, echocardiogram) on lemurs both in-bred (in France) and in the wild (in Madagascar) to try to identify mutant cardiac traits that may be heritable - and in the process, characterize the first high-throughput primate model of human cardiac disease. -
Ming Li (Estella) Chen
Postdoctoral Scholar, Cardiovascular Medicine
BioI am an MD from Chung Shan Medical University, Taiwan. Before coming to Stanford, I obtained my MS degree in epidemiology at Harvard T.H. Chan School of Public Health, Boston, MA, where I completed graduate training in clinical, pharmacologic, and genetic epidemiology, and pursued advanced skills in biostatistics and causal inference.
My past research focused on real-world epidemiology studies using patient registries and national health insurance databases to elucidate the predictors or risk factors of immunologic diseases. For my graduate study, I conducted pharmacoepidemiology studies using electronic health record (EHR) data to elucidate the predictors of anti-drug antibodies development and its correlation to autoimmunity, to identify the generation of immunogenicity that may impact the effectiveness of monoclonal antibody therapies in individuals with autoimmune diseases. I gained experience in genetic data manipulation to investigate polymorphisms in response to monoclonal antibody therapies in asthma patients.
At Stanford, I am involved in research on the identification of molecular determinants of cardiometabolic diseases. -
Paul Cheng MD PhD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Cheng is a Cardiologist at Stanford University School of Medicine in the Department of Medicine and a member of the Cardiovascular Research Institute. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. Dr. Cheng completed internal medicine residency and cardiology fellowship at Stanford. His current clinical focus is in amyloidosis and cardio-oncology. During his post doctoral research in the Quertermous lab, he pioneered the application of single cell transcriptomic and epigenetic techniques to study human vascular diseases including atherosclerosis and aneurysm, and applied these techniques to investigate molecular mechanisms behind genetic risk factors for several human vascular diseases including atherosclerosis, and aortopathies such as Marfan's and Loey-Dietz syndrome.
The Cheng lab takes a patient-to-bench-to-bedside approach to science. The lab focuses on elucidating new pathogenic mechanisms of human vascular diseases through combing human genetics and primary vascular disease tissues, with high-resolution transcriptomic and epigenetic profiling to generate novel hypothesis that are then tested in a variety of in vitro and in vivo models. The lab is focused on two broad questions: (1) understanding the biological underpinning of the differences in diseases propensities of different arterial segments in an individual (i.e. why do you have atherosclerosis and aneurysms in certain segments but not others), and (2) understanding the role of perivascular fibroblast in human vascular diseases.
Find out more about what the Cheng lab is up to, check out https://chenglab.stanford.edu -
Ricardo Chia M.D.
Fellow in Medicine - Med/Cardiovascular Medicine
BioDr. Chia completed his undergraduate studies in Biological Sciences at the University of California, Davis. He went on to earn his medical degree from George Washington University School of Medicine. He then completed his internal medicine training at the University of Illinois Hospital and the University of Texas Southwestern Medical Center, where he also pursued further specialization in clinical hypertension and hypertensive disorders. Under the mentorship of Dr. Vongpatanasin, he received the Ruth L. Kirschstein National Research Service Award (NRSA) T32 research grant, through which he studied the effects of dietary inorganic phosphates on exercise capacity and hypertension. After completing his training in cardiovascular diseases at Thomas Jefferson University Hospitals, he joined the advanced heart failure and transplant cardiology fellowship here at Stanford University.
Dr. Chia has interests in right ventricular failure, pulmonary hypertension, HFpEF, hypertensive cardiomyopathies, transplant cardiology, cardiac hemodynamics, mechanical circulatory support, and ventricular assist devices. -
Daniel Clark, MD, MPH
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Pediatrics - CardiologyBioDr. Clark is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. He is also a clinical assistant professor with dual appointments in the Division of Cardiovascular Medicine, Department of Medicine and the Division of Cardiology, Department of Pediatrics at Stanford University School of Medicine.
Dr. Clark specializes in the diagnosis and treatment of adult congenital heart disease (ACHD) and the management of congenital and acquired heart disease in children. His clinical focus involves the combined use of cardiac magnetic resonance (CMR) and other imaging techniques to evaluate patients with known or suspected cardiovascular disease. Dr. Clark’s extensive training and experience with these techniques include multiple fellowships in adult cardiology, cardiovascular imaging, and ACHD.
Dr. Clark is currently a co-investigator on multiple research studies. During his fellowship, he received a training grant from the National Institutes of Health enabling evaluation of the ability of CMR to diagnose COVID-19-associated heart inflammation among college athletes. He currently uses CMR to assess heart transplant outcomes in donors positive for hepatitis C virus. Dr. Clark also received a research grant from the Adult Congenital Heart Disease Association supporting a randomized, controlled clinical trial of cardiac rehabilitation among patients with Fontan failure.
Dr. Clark serves as a peer reviewer for multiple prestigious journals, including The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Journal of the American Heart Association (JAHA). He serves on the editorial board for both JAHA and Circulation: Cardiovascular Imaging. He is also a member of numerous professional medical societies, including the American College of Cardiology, the American Heart Association, and the Adult Congenital Heart Association. -
William Clusin, MD
Associate Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsCardiac action potentials; tissue culture, voltage, clamp technique; role of calcium in ischemia arrhythmias; coronary, artery disease; myocardial infarction.
-
John P. Cooke, MD, PhD
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsOur translational research program in vascular regeneration is focused on generating and characterizing vascular cells from human induced pluripotential stem cells. We are also studying the therapeutic application of these cells in murine models of peripheral arterial disease. In these studies we leverage our longstanding interest in endothelial signaling, eg by nitric oxide synthase (NOS) as well as by nicotinic cholinergic receptors (nAChR).
-
Rajesh Dash, MD PhD; Director of SSATHI & CardioClick
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsI have two research areas:
1) Heart disease in South Asians - genetic, metabolic, & behavioral underpinnings of an aggressive phenotype.
2) Imaging cell injury & recovery in the heart. Using Cardiac MRI to visualize signals of early injury and facilitating preventive medical therapy. Optimizing new imaging methods for viable cells to delineate live heart cells or transplanted stem cells. -
Colette DeJong
Clinical Instructor, Medicine - Cardiovascular Medicine
BioDr. Colette DeJong is general cardiologist and health services researcher at Stanford University and the VA Palo Alto. A graduate of Brown University and the University of California, San Francisco School of Medicine, Dr. DeJong completed an internal medicine residency, chief residency, and fellowship in cardiovascular medicine at UCSF, as well as a two-year editorial fellowship at JAMA Internal Medicine and a research fellowship at the UCSF Center for Healthcare Value. Dr. DeJong’s research focuses on improving access to effective cardiovascular therapies. She is interested in developing and evaluating novel strategies to improve care delivery, such as cardiovascular combination pills (“polypills”). Dr. DeJong served as the principal investigator of a pilot clinical trial of heart failure polypills at Zuckerberg San Francisco General Hospital.
-
Timothy Joseph Devine
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioTimothy Devine is a board-certified cardiologist at Stanford Health Care and a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. In 2024, he joined the Stanford family from San Bernardino County Kaiser, where he practiced since 2011. Born and raised in the Philadelphia area, he relocated to California in 2001 to complete his Naval Residency in San Diego and later his General Cardiology Fellowship at Scripps Clinic with an associate fellowship in Integrative Medicine. At Kaiser, he was instrumental in creating several innovative projects: Cardiology Hospitalist Program dedicated to resident teaching, “Doc of the Day” - a team-based digital platform that proactively manages urgent outpatient cardiac issues, and a Cardiac Point-of-Care Ultrasound program. He is passionate about medical education, specifically teaching the art of medicine. For research, he hopes to explore ways to improve the healthcare delivery system to efficiently move people from patienthood to health. Personally, you may catch him exploring the Bay Area by bike, boat, or BART as he is eager to meet others for recreational or service opportunities to improve the health of our community.
-
Rajiv Doshi, MD
Adjunct Professor and Director, India Biodesign Program, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsDr. Rajiv Doshi serves as an Adjunct Professor of Medicine and as the Director of the India Program at the Byers Center for Biodesign. Dr. Doshi is also the co-Director of the India-based Founders Forum, an executive education training program for India’s leading health technology entrepreneurs. He has also advised the Government of India and various Indian state governments in the development of policies that support Indian health technology innovation.
-
Jaclyn Doyle, MS, RN, FNP-BC
Affiliate, Medicine - Med/Cardiovascular Medicine
BioJaclyn holds a Bachelor of Science in Nursing from The Johns Hopkins University School of Nursing in Baltimore, MD, and a Bachelor of Science in Public Health Education from the University of Wisconsin-LaCrosse. She earned her Master of Science degree from the University of Maryland School of Nursing where she completed her training as a Nurse Practitioner (NP). She is a nationally board-certified Nurse Practitioner with close to twenty (20) years of combined critical care and cardiovascular nursing experience. Jaclyn specializes in cardiovascular medicine with a current focus on interventional cardiology and structural heart disease.
-
Zachary Edmonds, MD, MBA
Academic Staff - Hourly - CSL, Medicine - Cardiovascular Medicine
Adjunct Professor, Medicine - Cardiovascular MedicineBioAdjunct Professor of Medicine | Cardiovascular Medicine | Stanford Medicine
Seasoned clinician with a proven track record of mentoring medtech entrepreneurs and early stage companies in the development of life changing technologies. As the Associate Director of the PAMF Hospital Medicine service line he co-leads a team of 30 physicians across 3 community hospitals in the Bay Area. When not seeing patients, he serves as the Chief Medical Officer at Fogarty Innovation where he mentors a variety of early stage companies. As an Adjunct Professor of Medicine at Stanford he works closely with the Biodesign group to teach and mentor students and Biodesign fellows. He co-teaches the Biodesign Innovation graduate course which is offered to Stanford graduate students in the school of medicine, school of engineering and the graduate school of business each winter and spring quarter. Zach holds an MD from the UCLA School of Medicine and an MBA from the UCLA Anderson School of Management. He completed Internal Medicine Residency and the Biodesign Fellowship at Stanford University. -
Aly Elezaby, MD PhD
Instructor, Medicine - Cardiovascular Medicine
BioDr Aly Elezaby is an advanced heart failure and transplant cardiologist at Stanford University School of Medicine and a research scientist in the lab of Dr Daria Mochly-Rosen. He attended college at the University of Arizona, where he studied molecular and cellular biology with a research focus on mechanisms of genome instability. He graduated from the MD-PhD program at Boston University, with a dissertation focus on the effects of nutrient excess on mitochondrial function and oxidative stress in the heart. He completed residency training in internal medicine and cardiovascular medicine fellowship at Stanford as part of the Translational Investigator Program. His current research focus is on the signaling pathways that modulate cardiac ischemia-reperfusion injury, with a particular focus on regulation of metabolism and mitochondrial function. His clinical focus is on the management of inherited cardiovascular disease, advanced heart failure, transplant cardiology and mechanical circulatory support.
-
William Fearon, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Fearon's general research interest is coronary physiology. In particular, he is investigating invasive methods for evaluating the coronary microcirculation. His research is currently funded by an NIH R01 Award.
-
Peter Fitzgerald, MD, PhD
Professor (Research) of Medicine (Cardiovascular), Emeritus
BioDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor in both the Departments of Medicine and Engineering (by courtesy) at Stanford. Presently, Dr. Fitzgerald’s laboratory includes 17 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. He has led or participated in over 175 clinical trials, published over 550 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade. In addition, he heads the Stanford/Asia MedTech innovation program.
Dr. Fitzgerald has been principle/founder of twenty-one medical device companies in the San Francisco Bay Area. He has transitioned fourteen of these start-ups to large medical device companies. He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Peter was on the founding team of LVP Capital, a venture firm, focused on medical device and biotechnology start-ups in San Francisco. In 2009, he co-founded TriVentures, which is an incubator/venture fund for early stage medical technology in Israel. -
Michael B. Fowler, MBBS, FRCP
Professor of Medicine (Cardiovascular), Emeritus
Current Research and Scholarly InterestsAdrenergic nervous system; beta-adrenergic function in, heart failure; drugs in heart failure.
-
Victor Froelicher, MD
Professor of Medicine (Cardiovascular) at the Veterans Affairs Palo Alto Health Care System, Emeritus
Current Research and Scholarly InterestsScreening of athletes for sudden cardiac death, Computerized ECG and clinical data management; exercise Physiology including expired gas analysis; the effect of chronic and acute exercise on the heart; digital recording of biological signals; diagnostic use of exercise testing; development of Expert Medical System software and educational tools.
-
Daniel Aaron Gerber, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Gerber is a critical care cardiologist and co-director of Stanford's Cardiac ICU. He has dual subspecialty training in cardiovascular and critical care medicine and additional board certification in echocardiography. He completed his residency in internal medicine, fellowship in cardiovascular medicine, and an additional fellowship in critical care medicine at Stanford University and joined as faculty in 2021 as a Clinical Assistant Professor in the Department of Medicine’s Division of Cardiovascular Medicine.
Dr. Gerber manages the full spectrum of heart and vascular conditions with a focus on critically ill patients with life-threatening cardiovascular disease. He is active in medical education, teaching introductory echocardiography to Stanford medical students and residents, co-directing the Stanford Critical Care Medicine Critical Care Ultrasound Program, and lecturing nationally on critical care echocardiography and point-of-care ultrasonography at the Society of Critical Care Medicine’s annual congress. Finally, Dr. Gerber’s research interests focus on optimizing cardiac intensive care, including working with the Critical Care Cardiology Trials Network (CCCTN) - a national network of tertiary cardiac ICUs coordinated by the TIMI Study Group - and studying acute mechanical circulatory support techniques to improve patient outcomes and care processes. -
Joshua Gillard
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD in bioinformatics at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, high-throughput proteomics) derived from human observational or intervention studies (vaccination and experimental human infection) in order to discover molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is focused on applying deep learning models to investigate aberrant splicing in cardiovascular disease.
-
Diona Gjermeni
Affiliate, Med/Stanford Center for Clinical Research
Visiting Scholar, Medicine - Med/Cardiovascular MedicineBioDiona Gjermeni is a board-certified physician specialized in both Internal Medicine and Cardiology (Germany). With a strong focus on clinical research, her previous work primarily revolves around antithrombotic therapy and personalized medicine.
Currently affiliated with Stanford University, as a research fellow she is actively engaged in the Stanford Center for Clinical Research (SCCR), where he is gaining expertise in the conduct of clinical trials within the field of cardiovascular medicine. She is currently involved in a variety of clinical trials spanning multiple phases, with a particular emphasis on digital health, heart failure, and arrhythmias. Her research aims to improve patient outcomes through innovative therapies and precision medicine. Looking ahead, Dr. Gjermeni's long-term professional goal is to specialize in Electrophysiology, where she hopes to contribute further to the advancement of cardiovascular care. -
Bruna Gomes
Postdoctoral Scholar, Cardiovascular Medicine
Current Research and Scholarly InterestsThe increasing availability of very large datasets, along with recent advances in deep learning based tools for automatic extraction of cardiac traits, has led to the discovery of further common variants associated with cardiac disease. However, the genetic underpinnings of valvular heart disease remains understudied. I am interested in developing deep learning techniques to automatically extract cardiac flow information to facilitate genome-wide association studies of cardiac flow traits.
-
Francois Haddad
Clinical Professor, Medicine - Cardiovascular Medicine
BioDr. Francois Haddad, MD is a Clinical Professor of Medicine that specializes in the field of cardio-vascular imaging, pulmonary hypertension, advanced heart failure and transplantation. Dr. Haddad has over 18 years of practice in the field of cardiology. He directs Stanford Cardiovascular Institute Biomarker and Phenotypic Core Laboratory dedicated to translational studies in cardiovascular medicine. The laboratory focuses on (1) identifying early biomarkers of heart failure and aging, (2) bioengineering approaches to cardiovascular disease modeling and (3) novel informatic approach for the detection and risk stratification of disease. He is involved is several precision medicine initiatives in health including the Project Baseline, the Integrated Personalized Omics Profiling Initiative, the Athletic screening program at Stanford and the Strong-D cardiac rehabilitation initiative in individuals with diabetes mellitus.
-
Christiane Haeffele
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Pediatrics - CardiologyCurrent Research and Scholarly InterestsAdult Congenital Heart Disease
-
William Haskell
Professor (Research) of Medicine, Emeritus
Current Research and Scholarly InterestsMy major research interests and activities over the next several years will focus on the development and evaluation of the objective measurement of physical activity in free-living populations using a variety of sensing devices and mobile phones for data collection and processing. Also, I will continue to direct the Stanford Heart Network with the major mission being to assist community-based CVD prevention/treatment programs implement more effective heart attack and stroke prevention programs.
-
Paul Heidenreich, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsMy research interests include
1) The cost-effectiveness of new cardiovascular technologies.
Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.
2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.
3) Outcomes research using existing clinical and administrative datasets.
4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction). -
Mark Hlatky, MD
Professor of Health Policy, of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.
-
Benjamin Davies Horne
Adjunct Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. Benjamin Horne is an Adjunct Clinical Associate Professor who is based at the Intermountain Medical Center Heart Institute in Salt Lake City, UT, where he serves as the Director of Cardiovascular and Genetic Epidemiology. His doctoral training (PhD) in genetic epidemiology was completed at the University of Utah and he holds masters degrees in public health and in biostatistics. Dr. Horne is a fellow of the American Heart Association, a fellow of the American College of Cardiology, and a member of the American Society of Human Genetics. Dr. Horne’s research focuses on population health and precision medicine, including evaluating the genetic epidemiology of heart diseases, developing and implementing clinical decision tools for personalizing medical care, discovering the human health effects of intermittent fasting, and studying the influences of air pollution on major adverse health events.
-
Stephanie Hsiao, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Stephanie Hsiao is a clinical assistant professor at Stanford Medicine and a full-time advanced heart failure/transplant cardiologist at the Palo Alto VA. She grew up in Taipei, Taiwan. She attended undergraduate at UC Berkeley and obtained her Master’s degree in Pharmacology at Cambridge University in the UK. She obtained her M.D. from UC San Francisco. She completed her Internal Medicine residency and General Cardiology fellowship at the California Pacific Medical Center in San Francisco, where she served as the chief resident and chief cardiology fellow. She completed her advanced heart failure/transplant cardiology fellowship at Stanford in June 2022 and joined the Stanford Faculty soon after. She has a strong interest in medical education and quality improvement. Her clinical interests include HF outreach in the VA health care systems, women’s heart health, and AHFTX fellowship curriculum design/development. Her research interests include multi-organ transplantations and advocacy of diversity-equity-inclusion in advanced HF therapies. She plans to lead a career in medical education and quality improvement to deliver exceptional and equitable care for patients needing advanced HF therapies.
-
Hirotaka Ieki
Postdoctoral Scholar, Cardiovascular Medicine
BioCardiologist in Japan.
Research interest: precision medicine in cardiovascular disease. Genomics, Exposomics. -
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Fumiaki Ikeno
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
Researcher Cardiovascular Medicine, Stanford University
Faculty of Japan Reach, CARE (Center for Asian Health Research and Education) , Stanford University
Co-Director of Asia, SPARK Global, Stanford SPARK , Stanford University
Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.
Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.
Contact Information
Falk CVRC CV007
300 Pasteur Drive
Palo Alto, CA 94305-5406 -
Hiroyuki Inoue
Postdoctoral Scholar, Cardiovascular Medicine
BioPhysician-scientist passionate about bridging research findings and clinical practice
- Board certified cardiologist with 10+ years clinical experience, focused on cardiovascular diseases including heart failure, ischemic heart disease, arrhythmia, and general internal medicine
- Experience of 400+ cases as the primary operator in percutaneous coronary intervention, catheter ablation, and cardiac device implantation
- Research expertise in extracelluler vesicles, regenerative medicine, genome editing and gene therapy
Dr. Inoue joined the Yang lab in 2022. His research aim is the development of novel regenerative therapeutics for heart failure. -
Sneha Shah Jain MD, MBA
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sneha S. Jain is a Clinical Assistant Professor in the Division of Cardiovascular Medicine. She specializes in general cardiovascular medicine and preventive cardiology.
She received her MD from the Johns Hopkins School of Medicine and her MBA from Harvard Business School. She graduated with distinction from Duke University with a BS in Economics. She completed internal medicine resident training at Columbia/NewYork-Presbyterian, during which time she was selected as a Silverman Fellow in Healthcare Innovation. In this capacity, she worked with clinical and data science partners to build and deploy the technological infrastructure to identify patients with certain cardiac conditions earlier in the course of their disease. She subsequently pursued fellowship training in cardiovascular medicine at Stanford University prior to joining faculty.
Her research focuses on the development and responsible evaluation of AI to augment healthcare delivery and improve patient outcomes in cardiology. She works with the Stanford Center for Clinical Research and the Data Science Team at Stanford to deploy and prospectively evaluate AI solutions across the healthcare enterprise. -
Mehrnaz Nicole Jamali MD
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. M. Nicole Jamali focus has been in leadership, scientific innovation and streamlining business ventures. Over the past 20 years since graduation from Stanford Internal Medicine Residency, she has held National Positions in AMA as Western Caucus Chair and Appointee to Joint Commission Board. She was reelected to Board of Joint Commission three terms for total of 9 years. She helped rewrite multiple TJC Standards including creation of the Stroke Center of excellence standards and annual "new ideas section of the board". At AMA she authored and passed multiple House rules on variety of subjects affecting thousands of providers and healthcare centers. Her experiences in private practice, group practice, Hospitalist, Insurance Directorship lead to multiple innovative projects including first e-prescription covering both meds and DME in 1999 titled eRemedy,. She then created the first wrong site surgery device which was patented. This project lead to creation of first Transplant App called TPOD which was then simplified to TAPP. It was beta tested in USC and perfected in UCSF Transplant.
Her work with various Insurance companies resulted in streamlined programs and teaching modules improving patient access to health care and millions of dollars in hospital savings of unnecessary admissions.
Her work in creation and streamlining and connecting with local Primary Care providers resulted in rapid expansion of the Hospitalist program of local Hospital by 300%
She is currently interested in Haptic and AI technologies in Medicine and providing 24/7 care to our veterans in remote locations or even the battlefield.
She is currently Clinical Associated Professor and the lead Hospitalist in the new Stanford Cardiovascular Hospitalist Program and enjoys the daily interaction with patients . She truly believes that her mission in life is to be at the bedside of ill patients. She treats them as one of her own family. It is not atypical for her to hand out her personal phone number to make sure they feel safe even when discharged. -
Roy Mattathu John, MD, PhD, FRCP
Clinical Professor, Medicine - Cardiovascular Medicine
BioDr. John is a fellowship-trained cardiologist with more than 25 years of experience. He is a clinical professor in the Department of Medicine at Stanford University School of Medicine.
He originally earned board certification in clinical cardiac electrophysiology in 1996 and has continued to recertify. He also has earned board certification in cardiovascular disease and internal medicine.
Dr. John diagnoses and manages all forms of cardiac arrhythmias including atrial fibrillation and ventricular arrhythmias. His special interests include catheter ablation for SVT, atrial arrhythmias, pacemaker and defibrillator implants, and lead extraction.
He has conducted extensive research. He has participated in large multi-center clinical trials, including over 30 studies as a primary investigator of drugs, devices, and ablation techniques. He helped pioneer a new way to manage scar-related ventricular tachycardia. He also helped develop innovations in cardiac pacemaker technology.
Dr. John has authored over 200 publications that include 126 original research papers. They have appeared in reputed journals such as the New England Journal of Medicine, Circulation, Lancet, Journal of the American College of Cardiology, European Heart Journal, Heart Rhythm, Journal of Cardiovascular Electrophysiology, and many more. Topics have included innovative, new techniques and technologies for the treatment of supraventricular arrhythmias, atrial fibrillation, ventricular tachycardia, catheter ablation, lead extraction, cardiac pacing, and defibrillation.
He was a member of the editorial board for Circulation and is currently on the editorial board of the publications Heart Rhythm Journal, Arrhythmia and Electrophysiology, Journal of Cardiac Electrophysiology, and Journal of Innovations in Cardiac Rhythm Management.
Dr. John also has written several chapters for medical textbooks such as Harrison’s Principles of Internal Medicine, Zipes Textbook on Cardiac Electrophysiology - Cell to Bedside, Conn’s Current Therapy, Electrical Disorders of the Heart, Cardiac Mapping, and many more.
He has made invited presentations to his peers at scientific sessions of the Heart Rhythm Society, American Heart Association, American College of Cardiology, and Heart Failure Society. He has delivered more than 60 national and international lectures. Subjects include cardiac pacing, defibrillation, heart failure, and arrhythmia management including catheter ablation for arrhythmias.
Dr. John is a fellow of the American College of Cardiology, Heart Rhythm Society, and Royal College of Physicians of London.
He has volunteered his time and expertise to provide free cardiac care to underserved patients in Bolivia, India, and Kenya. -
Neil M. Kalwani
Clinical Instructor, Medicine - Cardiovascular Medicine
BioNeil Kalwani, MD, MPP is a Clinical Instructor in the Division of Cardiovascular Medicine and Director of Preventive Cardiology at the VA Palo Alto Health Care System. He attended college at Yale University and completed graduate degrees in medicine and public policy at Harvard University. He trained in internal medicine at Brigham and Women’s Hospital before arriving at Stanford in 2018 for fellowship in cardiovascular medicine, during which he served as Chief Fellow. He then completed a postdoctoral fellowship through the Stanford-AHRQ Health Services Research Training Program in the Department of Health Policy. His clinical focus is in general and preventive cardiology and echocardiography. He practices at the VA Palo Alto Health Care System and at Stanford Health Care.
Dr. Kalwani's research focuses on the evaluation of policies and care delivery innovations designed to improve the value of care for patients with cardiovascular disease. -
Guson Kang
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Kang is an interventional cardiologist who specializes in the treatment of structural heart disease. He has expertise in complex coronary interventions, transcatheter aortic and mitral valve replacements, transcatheter mitral valve repair, left atrial appendage occlusion, PFO/septal defect closure, alcohol septal ablation, and paravalvular leak closure.
A Bay Area native, he graduated from Stanford University and obtained his medical degree at Yale University. He came back to Stanford to train in internal medicine, cardiology, and interventional cardiology before completing an advanced structural interventions fellowship at Ford Hospital. -
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html -
Masataka Kawana
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Kawana joined the Advanced Heart Failure and Transplant Cardiology group in 2018. He completed his internal medicine, cardiovascular medicine, and heart failure training at Stanford. He also completed a postdoctoral research fellowship under Dr. James Spudich in the Department of Biochemistry. He is the Medical Director of Ambulatory Heart Failure and Cardiomyopathy Service in the Advanced Heart Failure program. He manages advanced heart failure patients in the clinic, CCU/heart failure service, and post-heart transplant/MCS service. His research interests are in the fundamental mechanism of inherited cardiomyopathies, and he studies the effect of gene mutation on the cardiac sarcomere function using cutting-edge biochemical and biophysical approaches, which would lead to the development of novel pharmacotherapy that directly modulates cardiac muscle protein. He is involved in multiple clinical trials for pharmacotherapy and novel device studies in heart failure and inherited cardiomyopathy.
-
Arash Keshavarzi
Postdoctoral Scholar, Cardiovascular Medicine
BioArash has a background in molecular biology and chemistry, and earned his PhD in AI-driven drug discovery, where his work led to the identification of three candidate drugs for breast cancer, validated both in vitro and in vivo. Following this, he joined a lab at UCSF for his first postdoctoral position which led to a patent for AI drug discovery applications which led to multiple patents and articles. Throughout his career, Arash has also been involved in multiple ventures. He served as the Chief Scientific Officer at Nucleus Genomics with $17 million seed funding, and co-founded Lumos Bio, a stealth focused on RNA-targeted drug discovery. Currently, Arash is a NIH T32 fellow postdoc in the Ashley Lab and an investment fellow in Mubadala Capital
-
Abha Khandelwal
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardiovascular disease in Pregnancy
Valvular Heart Disease
Cardiomyopathy
Pericardial disease
Heart Disease in South Asians
Women's Cardiovascular Disease -
Pik Fang Kho
Postdoctoral Scholar, Cardiovascular Medicine
BioI obtained my PhD in genetic epidemiology at Queensland University of Technology (Australia), where my research was focused on using genetic and genomic approaches to identify risk factors for endometrial cancer. During my graduate studies, I gained experience in large-scale genetic association studies and leveraging the correlation between diseases in genetic studies to identify novel genetic variants associated with endometrial cancer. I also developed expertise in various statistical genetic approaches in multi-omics data, including fine-mapping and colocalization analyses, to prioritize candidate causal variants and genes. I also gained extensive experience in genetic causal inference analysis to infer causality between risk factors and health outcomes.
My research focus since moving to Stanford has been the identification of genetic and non-genetic determinants of cardiometabolic diseases. I am currently involved in projects including large-scale genetic association studies, multi-trait analysis with correlated traits, development and validation of polygenic risk scores, integrative analyses with multi-omics data, as well as Mendelian randomization analyses to advance our understanding of the genetic and environmental factors that contribute to cardiometabolic diseases. -
Kiran Kaur Khush, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Khush's clinical research interests include the evaluation of donors and recipients for heart transplantation; mechanisms of adverse outcomes after heart transplantation, including cardiac allograft vasculopathy and antibody-mediated rejection; and development of non-invasive diagnostic approaches for post-transplant monitoring.
-
Gloria S. Kim
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsMedical education
Health services delivery
Management of chronic disease
Patient and physician satisfaction -
Juyong Brian Kim
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. The Cardiovascular Link to Environmental ActioN (CLEAN) Lab is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events. We intersect human genomic discoveries with animal models of disease, in-vitro and in-vivo systems of exposure, single-cell sequencing technologies to solve these questions. Additionally, we collaborate with various members of the Stanford community to develop biomarkers that will aid with detection and prognosis of CVD. We are passionate about the need to reduce the environmental effects on health through strong advocacy and outreach.
(http://kimlab.stanford.edu) -
Joshua W. Knowles
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsGenetic basis of coronary disease
Genetic basis of insulin resistance
Familial Hypercholesterolemia (FH)
